San Francisco startup Structure Therapeutics is also focusing on an oral, the moment-every day GLP-1 drug known as GSBR-1290—the drug surpassed Wall Avenue’s anticipations in June every time a mid-stage analyze confirmed common weight loss of about six% and it strategies to start Yet another mid-stage demo in the direction of the end of the 12